Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.30 (-0.75) | AIM:£3.24 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma